Advertisement

Topics

"A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients." Drugs and Medication Database

10:28 EDT 23rd October 2018 | BioPortfolio

Here are the most relevant "A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients." Drugs and Medications that we have found in our database.

More Information about "A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients." on BioPortfolio

We have published hundreds of A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients. news stories on BioPortfolio along with dozens of A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients. Clinical Trials and PubMed Articles about A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients. Companies in our database. You can also find out about relevant A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients. Drugs and Medications on this site too.

Showing "Study Subcutaneous Mircera Treatment Anemia Dialysis Patients" Drugs and Medications 1–25 of 310

Possibly Relevant

Sumatriptan succinate [Greenstone LLC]

Sumatriptan succinate [Aurobindo Pharma Limited]

Infergen [Three Rivers Pharmaceuticals, LLC]

These highlights do not include all the information needed to use INFERGEN® safely and effectively. See full prescribing information for INFERGEN. INFERGEN (interferon alfacon-1)injection for subcutaneous useInitial U.S. Approval: 1997

Nephrocaps [Fleming & Company, Pharmaceuticals]

NEPHROCAPS® - DIALYSIS/STRESS Vitamin Supplement

Nephrocaps [American Health Packaging]

NEPHROCAPS® - DIALYSIS/STRESS Vitamin Supplement

Sumatriptan succinate [Sun Pharma Global FZE]

Sumatriptan Succinate InjectionFor Subcutaneous Use Only.

Reno caps [Nnodum Pharmaceuticals]

Reno Caps

Pegasys [Genentech, Inc.]

These highlights do not include all the information needed to use PEGASYS safely and effectively. See full prescribing information for PEGASYS. PEGASYS® (peginterferon alfa-2a)Injection for Subcutaneous UseInitial U.S. Approval: 2002

Renal caps [Cypress Pharmaceutical, Inc.]

Renal Caps

Furosemide [Med-Health Pharma, LLC]

Dialyvite supreme d [Hillestad Pharmaceuticals USA]

Dialyvite Supreme D

Octreotide acetate [TEVA Parenteral Medicines, Inc.]

Octreotide Acetate Injection

Octreotide acetate [Sandoz Inc]

Octreotide Acetate Injection

Octreotide acetate [Sandoz Inc]

Octreotide Acetate Injection

Nephrocaps-qt [Fleming & Company, Pharmaceuticals]

NEPHROCAPSQT Quick-Dissolve TabletsDIALYSIS/RENAL Vitamin

Octreotide acetate [SUN PHARMACEUTICAL INDUSTRIES LIMITED]

Octreotide Acetate Injection

Sandostatin [Novartis Pharmaceuticals Corporation]

Sandostatin

Vidaza [Celgene Corporation]

These highlights do not include all the information needed to use VIDAZA safely and effectively. See full prescribing information for VIDAZA. VIDAZA (azacitidine for injection) for SC or IV useInitial U.S. Approval: 2004

Sumatriptan succinate [JHP Pharmaceuticals LLC]

Sumatriptan Succinate Injection

Octreotide acetate [Teva Parenteral Medicines, Inc]

Octreotide Acetate Injection

Octreotide acetate [Bedford Laboratories]

OCTREOTIDE ACETATE INJECTION

Octreotide acetate [Bedford Laboratories]

OCTREOTIDE ACETATE INJECTION

Sumatriptan succinate [Teva Parenteral Medicines, Inc]

Sumatriptan Succinate Injection

Sumatriptan succinate [APP Pharmaceuticals, LLC]

Sumatriptan Succinate Injection

Revlimid [Celgene Corporation]

These highlights do not include all the information needed to use REVLIMID safely and effectively. See full prescribing information for REVLIMID. REVLIMID (lenalidomide) capsules Initial U.S. Approval: 2005



Advertisement
Quick Search
Advertisement
Advertisement